|
||||||
|
 | Fusion Gene Summary |
| Fusion Gene ORF analysis |
| Fusion Genomic Features |
| Fusion Protein Features |
| Fusion Gene Sequence |
| Fusion Gene PPI analysis |
| Related Drugs |
| Related Diseases |
Fusion gene:EIF4G2-APOBEC3C (FusionGDB2 ID:25990) |
Fusion Gene Summary for EIF4G2-APOBEC3C |
 Fusion gene summary |
| Fusion gene information | Fusion gene name: EIF4G2-APOBEC3C | Fusion gene ID: 25990 | Hgene | Tgene | Gene symbol | EIF4G2 | APOBEC3C | Gene ID | 1982 | 27350 |
| Gene name | eukaryotic translation initiation factor 4 gamma 2 | apolipoprotein B mRNA editing enzyme catalytic subunit 3C | |
| Synonyms | AAG1|DAP5|NAT1|P97 | A3C|APOBEC1L|ARDC2|ARDC4|ARP5|PBI|bK150C2.3 | |
| Cytomap | 11p15.4 | 22q13.1 | |
| Type of gene | protein-coding | protein-coding | |
| Description | eukaryotic translation initiation factor 4 gamma 2DAP-5aging-associated protein 1death-associated protein 5eIF-4-gamma 2eIF-4G 2eIF4G 2eukaryotic translation initiation factor 4G-like 1 | DNA dC->dU-editing enzyme APOBEC-3Capolipoprotein B editing enzyme catalytic polypeptide-like 3Capolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 3Cphorbolin Iprobable DNA dC->dU-editing enzyme APOBEC-3C | |
| Modification date | 20200313 | 20200313 | |
| UniProtAcc | P78344 | Q9NRW3 | |
| Ensembl transtripts involved in fusion gene | ENST00000526148, ENST00000525681, ENST00000339995, ENST00000396525, ENST00000525995, | ENST00000361441, | |
| Fusion gene scores | * DoF score | 23 X 17 X 10=3910 | 1 X 1 X 1=1 |
| # samples | 28 | 1 | |
| ** MAII score | log2(28/3910*10)=-3.80366987524975 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | log2(1/1*10)=3.32192809488736 | |
| Context | PubMed: EIF4G2 [Title/Abstract] AND APOBEC3C [Title/Abstract] AND fusion [Title/Abstract] | ||
| Most frequent breakpoint | EIF4G2(10820973)-APOBEC3C(39414011), # samples:1 | ||
| Anticipated loss of major functional domain due to fusion event. | |||
| * DoF score (Degree of Frequency) = # partners X # break points X # cancer types ** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10) |
| Gene ontology of each fusion partner gene with evidence of Inferred from Direct Assay (IDA) from Entrez |
| Partner | Gene | GO ID | GO term | PubMed ID |
| Hgene | EIF4G2 | GO:0006446 | regulation of translational initiation | 11943866 |
| Tgene | APOBEC3C | GO:0009972 | cytidine deamination | 21632763 |
| Tgene | APOBEC3C | GO:0010529 | negative regulation of transposition | 16527742|20062055 |
| Tgene | APOBEC3C | GO:0045071 | negative regulation of viral genome replication | 21632763 |
| Tgene | APOBEC3C | GO:0080111 | DNA demethylation | 21496894 |
| Fusion gene breakpoints across EIF4G2 (5'-gene) * Click on the image to open the UCSC genome browser with custom track showing this image in a new window. |
| Fusion gene breakpoints across APOBEC3C (3'-gene) * Click on the image to open the UCSC genome browser with custom track showing this image in a new window. |
| Fusion gene information from two resources (ChiTars 5.0 and ChimerDB 4.0) * All genome coordinats were lifted-over on hg19. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
| Source | Disease | Sample | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
| ChiTaRS5.0 | N/A | BF914332 | EIF4G2 | chr11 | 10820973 | + | APOBEC3C | chr22 | 39414011 | + |
Top |
Fusion Gene ORF analysis for EIF4G2-APOBEC3C |
| Open reading frame (ORF) analsis of fusion genes based on Ensembl gene isoform structure. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
| ORF | Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
| intron-3CDS | ENST00000526148 | ENST00000361441 | EIF4G2 | chr11 | 10820973 | + | APOBEC3C | chr22 | 39414011 | + |
| intron-3CDS | ENST00000525681 | ENST00000361441 | EIF4G2 | chr11 | 10820973 | + | APOBEC3C | chr22 | 39414011 | + |
| intron-3CDS | ENST00000339995 | ENST00000361441 | EIF4G2 | chr11 | 10820973 | + | APOBEC3C | chr22 | 39414011 | + |
| intron-3CDS | ENST00000396525 | ENST00000361441 | EIF4G2 | chr11 | 10820973 | + | APOBEC3C | chr22 | 39414011 | + |
| intron-3CDS | ENST00000525995 | ENST00000361441 | EIF4G2 | chr11 | 10820973 | + | APOBEC3C | chr22 | 39414011 | + |
| ORFfinder result based on the fusion transcript sequence of in-frame fusion genes. |
| Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | Seq length (transcript) | BP loci (transcript) | Predicted start (transcript) | Predicted stop (transcript) | Seq length (amino acids) |
| DeepORF prediction of the coding potential based on the fusion transcript sequence of in-frame fusion genes. DeepORF is a coding potential classifier based on convolutional neural network by comparing the real Ribo-seq data. If the no-coding score < 0.5 and coding score > 0.5, then the in-frame fusion transcript is predicted as being likely translated. |
| Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | No-coding score | Coding score |
Top |
Fusion Genomic Features for EIF4G2-APOBEC3C |
| FusionAI prediction of the potential fusion gene breakpoint based on the pre-mature RNA sequence context (+/- 5kb of individual partner genes, total 20kb length sequence). FusionAI is a fusion gene breakpoint classifier based on convolutional neural network by comparing the fusion positive and negative sequence context of ~ 20K fusion gene data. From here, we can have the relative potentency of the 20K genomic sequence how individual sequnce will be likely used as the gene fusion breakpoints. |
| Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | 1-p | p (fusion gene breakpoint) |
| Distribution of 44 human genomic features loci across 20kb length fusion breakpoint regions. We integrated a total of 44 different types of human genomic feature loci information across five big categories including virus integration sites, repeats, structural variants, chromatin states, and gene expression regulation. More details are in help page. |
| Distribution of 44 human genomic features loci across 20kb length fusion breakpoint regions that are ovelapped with the top 1% feature importance score regions. More details are in help page. |
Top |
Fusion Protein Features for EIF4G2-APOBEC3C |
| Go to FGviewer for the breakpoints of :-: - FGviewer provides the online visualization of the retention search of the protein functional features across DNA, RNA, protein, and pathological levels. |
 |
| Main function of each fusion partner protein. (from UniProt) |
| Hgene | Tgene |
| EIF4G2 | APOBEC3C |
| FUNCTION: Appears to play a role in the switch from cap-dependent to IRES-mediated translation during mitosis, apoptosis and viral infection. Cleaved by some caspases and viral proteases. {ECO:0000269|PubMed:11511540, ECO:0000269|PubMed:11943866, ECO:0000269|PubMed:9032289, ECO:0000269|PubMed:9049310}. | FUNCTION: DNA deaminase (cytidine deaminase) which acts as an inhibitor of retrovirus replication and retrotransposon mobility via deaminase-dependent and -independent mechanisms. After the penetration of retroviral nucleocapsids into target cells of infection and the initiation of reverse transcription, it can induce the conversion of cytosine to uracil in the minus-sense single-strand viral DNA, leading to G-to-A hypermutations in the subsequent plus-strand viral DNA. The resultant detrimental levels of mutations in the proviral genome, along with a deamination-independent mechanism that works prior to the proviral integration, together exert efficient antiretroviral effects in infected target cells. Selectively targets single-stranded DNA and does not deaminate double-stranded DNA or single- or double-stranded RNA. Exhibits antiviral activity against simian immunodeficiency virus (SIV), hepatitis B virus (HBV), herpes simplex virus 1 (HHV-1) and Epstein-Barr virus (EBV) and may inhibit the mobility of LTR and non-LTR retrotransposons. May also play a role in the epigenetic regulation of gene expression through the process of active DNA demethylation. {ECO:0000269|PubMed:12859895, ECO:0000269|PubMed:15466872, ECO:0000269|PubMed:16527742, ECO:0000269|PubMed:20062055, ECO:0000269|PubMed:21496894, ECO:0000269|PubMed:21632763}. |
| Retention analysis result of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features. Here, because of limited space for viewing, we only show the protein feature retention information belong to the 13 regional features. All retention annotation result can be downloaded at * Minus value of BPloci means that the break pointn is located before the CDS. |
| - In-frame and retained protein feature among the 13 regional features. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
| - In-frame and not-retained protein feature among the 13 regional features. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Top |
Fusion Gene Sequence for EIF4G2-APOBEC3C |
| For in-frame fusion transcripts, we provide the fusion transcript sequences and fusion amino acid sequences. To have fusion amino acid sequence, we ran ORFfinder and chose the longest ORF among the all predicted ones. |
Top |
Fusion Gene PPI Analysis for EIF4G2-APOBEC3C |
| Go to ChiPPI (Chimeric Protein-Protein interactions) to see the chimeric PPI interaction in |
| Protein-protein interactors with each fusion partner protein in wild-type (BIOGRID-3.4.160) |
| Hgene | Hgene's interactors | Tgene | Tgene's interactors |
| - Retained PPIs in in-frame fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Still interaction with |
| - Lost PPIs in in-frame fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
| - Retained PPIs, but lost function due to frame-shift fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Top |
Related Drugs for EIF4G2-APOBEC3C |
| Drugs targeting genes involved in this fusion gene. (DrugBank Version 5.1.8 2021-05-08) |
| Partner | Gene | UniProtAcc | DrugBank ID | Drug name | Drug activity | Drug type | Drug status |
Top |
Related Diseases for EIF4G2-APOBEC3C |
| Diseases associated with fusion partners. (DisGeNet 4.0) |
| Partner | Gene | Disease ID | Disease name | # pubmeds | Source |
| Tgene | APOBEC3C | C0033975 | Psychotic Disorders | 1 | PSYGENET |
| Tgene | APOBEC3C | C0349204 | Nonorganic psychosis | 1 | PSYGENET |
Copyright 2021-Present -The University of Texas Health Science Center at Houston (UTHealth)
Web File Viewing | Emergency Information |Campus Carry|Site Policies